Eli L. Thomssen
Founder chez Apjohn Group LLC
Profil
Eli L.
Thomssen was the founder of Armune BioScience, Inc. (founded in 2008) and Adlore, Inc. (founded in 2019) where he held the titles of Chief Business Officer and Chairman respectively.
Mr. Thomssen's current job is as a Director at Esperovax, Inc. Mr. Thomssen's former jobs include Director & Principal at Sierra Oncology, Inc., Director at MedElute, Inc., Director at Vestaron Corp., VP-Business Development & Strategic Planning at Pharmacia & Upjohn, Inc., and Principal at The Upjohn Co. Mr. Thomssen received an undergraduate degree from the University of Nebraska and an MBA from Western Michigan University.
Mr. Thomssen is also the founder of Afmedica, Inc., Azenic, Inc., Apjohn Group LLC.
Postes actifs de Eli L. Thomssen
| Sociétés | Poste | Début |
|---|---|---|
Apjohn Group LLC
 Apjohn Group LLC Financial ConglomeratesFinance Apjohn Group LLC invests in pharamaceutical companies. It works with innovators to launch life science companies. The company is headquartered in Kalamazoo, MI. | Founder | 01/01/2005 |
Adlore, Inc.
 Adlore, Inc. Medical/Nursing ServicesHealth Services Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry. | Founder | 01/01/2019 |
Esperovax, Inc.
 Esperovax, Inc. Pharmaceuticals: MajorHealth Technology Esperovax, Inc. develops capsule vaccines. The company is based in Plymouth, MI. The company was founded by David O'Hagan, Roger S. Newton, Savita Nikam. Robin A. Robinson has been the CEO of the company since 2023. | Director/Board Member | - |
Anciens postes connus de Eli L. Thomssen
| Sociétés | Poste | Fin |
|---|---|---|
Armune BioScience, Inc.
 Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Founder | 01/12/2016 |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
MedElute, Inc.
 MedElute, Inc. Electronic Equipment/InstrumentsElectronic Technology MedElute Inc. developed drug-eluting materials for treating post-surgical adhesions. Post-surgical adhesion formation is a natural consequence of surgery, resulting when tissue repairs itself following incision, cauterization, suturing, or other means of trauma. The company was founded in 2005 and is headquartered in Kalamazoo, MI. | Director/Board Member | - |
| SIERRA ONCOLOGY, INC. | Director/Board Member | - |
Afmedica, Inc.
 Afmedica, Inc. Pharmaceuticals: MajorHealth Technology Afmedica, Inc. develops medical and drug products. It develops perivascular technology using the drug rapamycin to treat peripheral vascular disease, coronary artery disease, and end stage renal disease. The company was founded in 2002 and is located in Kalamazoo, MI. | Founder | - |
Formation de Eli L. Thomssen
| University of Nebraska | Undergraduate Degree |
| Western Michigan University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
| The Upjohn Co. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Afmedica, Inc.
Afmedica, Inc. Pharmaceuticals: MajorHealth Technology Afmedica, Inc. develops medical and drug products. It develops perivascular technology using the drug rapamycin to treat peripheral vascular disease, coronary artery disease, and end stage renal disease. The company was founded in 2002 and is located in Kalamazoo, MI. | Health Technology |
Azenic, Inc.
 Azenic, Inc. Medical SpecialtiesHealth Technology Azenic, Inc. manufactured and marketed dental devices. Its product DHP, was commercially launched to advance infection prevention and prevent cross-contamination in the dental office while offering an excellent stand-in product for use in difficult dental applications such as crown and bridge work, certain surgical applications and as a guaranteed back-up for a dentists busy days. The company was founded in September 2005 and was headquartered in Kalamazoo, MI. | Health Technology |
MedElute, Inc.
MedElute, Inc. Electronic Equipment/InstrumentsElectronic Technology MedElute Inc. developed drug-eluting materials for treating post-surgical adhesions. Post-surgical adhesion formation is a natural consequence of surgery, resulting when tissue repairs itself following incision, cauterization, suturing, or other means of trauma. The company was founded in 2005 and is headquartered in Kalamazoo, MI. | Electronic Technology |
Vestaron Corp.
 Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Process Industries |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Health Services |
Apjohn Group LLC
Apjohn Group LLC Financial ConglomeratesFinance Apjohn Group LLC invests in pharamaceutical companies. It works with innovators to launch life science companies. The company is headquartered in Kalamazoo, MI. | Finance |
Adlore, Inc.
Adlore, Inc. Medical/Nursing ServicesHealth Services Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry. | Health Services |
Esperovax, Inc.
Esperovax, Inc. Pharmaceuticals: MajorHealth Technology Esperovax, Inc. develops capsule vaccines. The company is based in Plymouth, MI. The company was founded by David O'Hagan, Roger S. Newton, Savita Nikam. Robin A. Robinson has been the CEO of the company since 2023. | Health Technology |
